Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial

Mehmet Ergelen1, Sevket Gorgulu, Huseyin Uyarel

  • 1Dept. of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Centre, Training and Research Hospital, Istanbul, Turkey. drmerg@hotmail.com

Acta Cardiologica
|February 5, 2010
PubMed

Insights

Ischaemic stroke occurs in 0.73% of ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI), increasing mortality. Low ejection fraction and contrast nephropathy predict stroke, while tirofiban may offer protection.

Area of Science:

  • Cardiology
  • Neurology
  • Interventional Cardiology

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical condition requiring timely intervention.
  • Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
  • Ischaemic stroke is a serious complication that can occur during or after PCI.

Purpose of the Study:

  • To determine the in-hospital incidence of ischaemic stroke in STEMI patients undergoing primary PCI.
  • To identify predictors of ischaemic stroke in this patient population.
  • To assess the impact of ischaemic stroke on in-hospital cardiovascular mortality.

Main Methods:

  • Retrospective review of 2638 consecutive STEMI patients undergoing 2722 primary PCI procedures.
  • Definition of ischaemic stroke: new focal neurological deficit lasting > or =24 hours, excluding haemorrhagic stroke.
  • Analysis of clinical characteristics and in-hospital outcomes related to ischaemic stroke.

Main Results:

  • Ischaemic stroke incidence was 0.73% (20/2722 procedures).
  • Stroke patients were older, with higher prevalence of female gender, diabetes, and hypertension.
  • Independent predictors for ischaemic stroke included left ventricular ejection fraction (LVEF) < 35% and contrast-induced nephropathy; tirofiban use showed a protective effect.

Conclusions:

  • Ischaemic stroke incidence in STEMI patients undergoing PCI is significant and associated with increased in-hospital mortality.
  • Low LVEF (<35%) and contrast-induced nephropathy are independent predictors of ischaemic stroke.
  • Tirofiban use may have a protective role against ischaemic stroke in STEMI patients undergoing PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...